Your browser doesn't support javascript.
loading
Clinical and economic burden of severe asthma among US patients treated with biologic therapies.
Reibman, Joan; Tan, Laren; Ambrose, Chris; Chung, Yen; Desai, Pooja; Llanos, Jean-Pierre; Moynihan, Meghan; Tkacz, Joseph.
Affiliation
  • Reibman J; Department of Medicine, NYU Langone Health, New York, New York. Electronic address: Joan.Reibman@nyulangone.org.
  • Tan L; Department of Medicine, Loma Linda University Health, Loma Linda, California.
  • Ambrose C; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland.
  • Chung Y; Payer Evidence, AstraZeneca, Gaithersburg, Maryland.
  • Desai P; Amgen Inc, Thousand Oaks, California.
  • Llanos JP; Amgen Inc, Thousand Oaks, California.
  • Moynihan M; IBM Watson Health, Cambridge, Massachusetts.
  • Tkacz J; IBM Watson Health, Cambridge, Massachusetts.
Ann Allergy Asthma Immunol ; 127(3): 318-325.e2, 2021 09.
Article in En | MEDLINE | ID: mdl-33775904

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Biological Products / Anti-Asthmatic Agents Type of study: Health_economic_evaluation / Observational_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Biological Products / Anti-Asthmatic Agents Type of study: Health_economic_evaluation / Observational_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Ann Allergy Asthma Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article